Acceptability of HIV Pre-exposure Prophylaxis (PrEP) Among People Who Inject Drugs (PWID) in a Canadian Setting

被引:0
作者
Daniel J. Escudero
Thomas Kerr
Evan Wood
Paul Nguyen
Mark N. Lurie
Omar Sued
Brandon D. L. Marshall
机构
[1] Brown University,Department of Epidemiology, School of Public Health
[2] St. Paul’s Hospital,British Columbia Centre for Excellence in HIV/AIDS
[3] University of British Columbia,Department of Medicine
[4] Fundación Huésped,undefined
来源
AIDS and Behavior | 2015年 / 19卷
关键词
PrEP; PWID; Acceptability; HIV; Risk behavior;
D O I
暂无
中图分类号
学科分类号
摘要
A recent clinical trial provided evidence that pre-exposure prophylaxis (PrEP) has the potential to prevent HIV infection among people who inject drugs (PWID). We examined willingness to use PrEP among HIV-negative PWID in Vancouver, Canada (n = 543) to inform PrEP implementation efforts. One third (35.4 %) expressed willingness to use PrEP, with adjusted models indicating that younger age, no regular employment, requiring help injecting, engaging in sex work, and reporting multiple recent sexual partners were positively associated with willingness to use PrEP. Although willingness to use PrEP was low, PrEP was acceptable to some PWID at heightened risk for HIV infection.
引用
收藏
页码:752 / 757
页数:5
相关论文
共 112 条
  • [1] Baeten JM(2012)Antiretroviral prophylaxis for HIV prevention in heterosexual men and women N Engl J Med. 367 399-410
  • [2] Donnell D(2010)Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women Science 329 1168-1174
  • [3] Ndase P(2010)Preexposure chemoprophylaxis for HIV prevention in men who have sex with men N Engl J Med 363 2587-2599
  • [4] Mugo NR(2013)Antiretroviral prophylaxis for HIV infection in injecting drug users in bangkok, thailand (the bangkok tenofovir study): a randomised, double-blind, placebo-controlled phase 3 trial Lancet 381 2083-2090
  • [5] Campbell JD(2014)Effectiveness and cost effectiveness of oral pre-exposure prophylaxis in a portfolio of prevention programs for injection drug users in mixed HIV epidemics PLOS ONE 9 E86584-568
  • [6] Wangisi J(2012)The potential uses of preexposure prophylaxis for HIV prevention among people who inject drugs Curr Opin HIV AIDS. 7 563-S69
  • [7] Abdool Karim Q(2013)Antiretroviral prophylaxis for sexual and injection drug use acquisition of HIV Am J Prev Med 44 S63-S87
  • [8] Abdool Karim SS(2010)Progress in HIV reduction and prevention among injection and noninjection drug users J Acquir Immune Defic Syndr 55 S84-S136
  • [9] Frohlich JA(2013)Disseminating HIV pre-exposure prophylaxis information in underserved communities Am J Prev Med 44 S133-1453
  • [10] Grobler AC(2014)HIV pre-exposure prophylaxis for people who inject drugs: a review of current results and an agenda for future research J Int AIDS Soc. 17 18899-539